We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current SNPX market cap is 96.04M. The company's latest EPS is USD -0.6757 and P/E is -6.97.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.17M | -5.89M | -2.92M | -1.83M | -1.43M |
| Net Income | -3.03M | 4.37M | -1.98M | -10.21M | -362k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.51M | -11.16M | -12.62M | -16.14M | -8.31M |
| Net Income | -15.14M | -15.13M | -12.61M | -5.69M | -13.78M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 27.35M | 38.61M | 36.53M | 33.44M | 32.36M |
| Total Liabilities | 684k | 3.19M | 2.34M | 6.53M | 3.93M |
| Total Equity | 26.67M | 32.69M | 31.46M | 24.83M | 26.74M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 17.9M | 6.75M | 35.53M | 38.61M | 31.11M |
| Total Liabilities | 479k | 1.61M | 2M | 3.19M | 5.53M |
| Total Equity | 17.42M | 5.14M | 33.53M | 32.69M | 24.35M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.43M | -11.21M | -1.7M | -2.94M | -4.11M |
| Investing | -5k | -7k | -2k | -3k | -3k |
| Financing | 553k | 14.48M | N/A | -1.64M | -1.64M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.89M | -8.1M | -8.71M | -11.21M | -5.17M |
| Investing | -5k | -5k | -3k | -7k | -2M |
| Financing | 420k | -3.48M | 37.13M | 14.48M | -1.64M |
| Market Cap | 96.04M |
| Price to Earnings Ratio | -6.97 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.35 |
| Price to Book Ratio | 3.75 |
| Dividend Yield | - |
| Shares Outstanding | 20.39M |
| Average Volume (1 week) | 102.15k |
| Average Volume (1 Month) | 87.52k |
| 52 Week Change | -78.09% |
| 52 Week High | 47.00 |
| 52 Week Low | 3.5275 |
| Spread (Intraday) | 0.35 (6.93%) |
| Company Name | Synaptogenix Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.synaptogen.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
